Aqilion is a Swedish life science company. We believe the best source of new treatments comes from identifying, shaping and strengthening early drug innovation. We seek ideas that could potentially both improve patient quality of life and streamline health care. Aqilion harbors the backbone core management, financing resources and business administration together with a network of skilled competences and seek to match that with external sources of innovation from academia or industry. Aqilion pursues and transforms ideas aimed at testing and refining science into clinical translation. The goal is to deliver clinical proof-of-concept and an interesting value proposition to attract industrial partners fitted to drive the late phases of clinical development and commercialization.